nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SLC6A4—endogenous depression	0.519	0.587	CbGaD
Fluvoxamine—CYP2D6—endogenous depression	0.364	0.413	CbGaD
Fluvoxamine—SLC6A3—brainstem—endogenous depression	0.00107	0.0359	CbGeAlD
Fluvoxamine—SLC6A3—forebrain—endogenous depression	0.00103	0.0346	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—endogenous depression	0.00102	0.0341	CbGeAlD
Fluvoxamine—SLC6A4—brainstem—endogenous depression	0.000981	0.0329	CbGeAlD
Fluvoxamine—SLC6A4—forebrain—endogenous depression	0.000947	0.0317	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal cortex—endogenous depression	0.000871	0.0292	CbGeAlD
Fluvoxamine—SIGMAR1—pituitary gland—endogenous depression	0.000704	0.0236	CbGeAlD
Fluvoxamine—SLC6A3—midbrain—endogenous depression	0.000682	0.0229	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal gland—endogenous depression	0.000629	0.0211	CbGeAlD
Fluvoxamine—SLC6A4—midbrain—endogenous depression	0.000625	0.0209	CbGeAlD
Fluvoxamine—SIGMAR1—midbrain—endogenous depression	0.000621	0.0208	CbGeAlD
Fluvoxamine—SIGMAR1—thyroid gland—endogenous depression	0.000607	0.0203	CbGeAlD
Fluvoxamine—CYP2B6—adrenal cortex—endogenous depression	0.000569	0.0191	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—endogenous depression	0.000561	0.0188	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—endogenous depression	0.000549	0.0184	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—endogenous depression	0.00054	0.0181	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—endogenous depression	0.000528	0.0177	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—endogenous depression	0.000519	0.0174	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—endogenous depression	0.000514	0.0172	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—endogenous depression	0.000514	0.0172	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—endogenous depression	0.000495	0.0166	CbGeAlD
Fluvoxamine—CYP1A1—Melatonin metabolism and effects—MAOA—endogenous depression	0.000488	0.00562	CbGpPWpGaD
Fluvoxamine—CYP2E1—cardiovascular system—endogenous depression	0.000487	0.0163	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—endogenous depression	0.00048	0.0161	CbGeAlD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TPH1—endogenous depression	0.00048	0.00553	CbGpPWpGaD
Fluvoxamine—CYP1A1—Oxidative Stress—MAOA—endogenous depression	0.000475	0.00547	CbGpPWpGaD
Fluvoxamine—CYP2D6—brainstem—endogenous depression	0.000473	0.0158	CbGeAlD
Fluvoxamine—CYP1A2—Tryptophan metabolism—TPH1—endogenous depression	0.000472	0.00544	CbGpPWpGaD
Fluvoxamine—CYP1A2—Estrogen metabolism—COMT—endogenous depression	0.000459	0.00529	CbGpPWpGaD
Fluvoxamine—CYP2D6—forebrain—endogenous depression	0.000456	0.0153	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—endogenous depression	0.000455	0.0152	CbGeAlD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000445	0.00513	CbGpPWpGaD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00043	0.00496	CbGpPWpGaD
Fluvoxamine—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00043	0.00495	CbGpPWpGaD
Fluvoxamine—SLC6A3—brain—endogenous depression	0.000429	0.0144	CbGeAlD
Fluvoxamine—CYP1A2—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000413	0.00476	CbGpPWpGaD
Fluvoxamine—CYP1A2—thyroid gland—endogenous depression	0.000413	0.0139	CbGeAlD
Fluvoxamine—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000413	0.00476	CbGpPWpGaD
Fluvoxamine—CYP2B6—adrenal gland—endogenous depression	0.000411	0.0138	CbGeAlD
Fluvoxamine—CYP1A1—thyroid gland—endogenous depression	0.000408	0.0137	CbGeAlD
Fluvoxamine—CYP2C19—Melatonin metabolism and effects—MAOA—endogenous depression	0.000399	0.0046	CbGpPWpGaD
Fluvoxamine—SLC6A4—brain—endogenous depression	0.000393	0.0132	CbGeAlD
Fluvoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000393	0.00452	CbGpPWpGaD
Fluvoxamine—SIGMAR1—brain—endogenous depression	0.00039	0.0131	CbGeAlD
Fluvoxamine—CYP2B6—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000387	0.00446	CbGpPWpGaD
Fluvoxamine—CYP2E1—adrenal gland—endogenous depression	0.000385	0.0129	CbGeAlD
Fluvoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000384	0.00443	CbGpPWpGaD
Fluvoxamine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000384	0.00442	CbGpPWpGaD
Fluvoxamine—CYP2E1—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000379	0.00437	CbGpPWpGaD
Fluvoxamine—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000379	0.00436	CbGpPWpGaD
Fluvoxamine—CYP2E1—thyroid gland—endogenous depression	0.000372	0.0125	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—endogenous depression	0.000372	0.0125	CbGeAlD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000369	0.00425	CbGpPWpGaD
Fluvoxamine—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000367	0.00423	CbGpPWpGaD
Fluvoxamine—CYP1A1—endocrine gland—endogenous depression	0.000367	0.0123	CbGeAlD
Fluvoxamine—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.000364	0.00419	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TPH2—endogenous depression	0.000364	0.00419	CbGpPWpGaD
Fluvoxamine—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000363	0.00418	CbGpPWpGaD
Fluvoxamine—CYP3A5—endocrine gland—endogenous depression	0.000358	0.012	CbGeAlD
Fluvoxamine—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000358	0.00412	CbGpPWpGaD
Fluvoxamine—CYP2B6—endocrine gland—endogenous depression	0.000356	0.0119	CbGeAlD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000356	0.0041	CbGpPWpGaD
Fluvoxamine—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.000354	0.00408	CbGpPWpGaD
Fluvoxamine—CYP2C9—endocrine gland—endogenous depression	0.000353	0.0118	CbGeAlD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.000344	0.00397	CbGpPWpGaD
Fluvoxamine—CYP1A1—nervous system—endogenous depression	0.000343	0.0115	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—endogenous depression	0.000334	0.0112	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—endogenous depression	0.000333	0.0112	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—endogenous depression	0.00033	0.0111	CbGeAlD
Fluvoxamine—ABCB1—forebrain—endogenous depression	0.000328	0.011	CbGeAlD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000324	0.00373	CbGpPWpGaD
Fluvoxamine—CYP2B6—central nervous system—endogenous depression	0.000321	0.0108	CbGeAlD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000318	0.00367	CbGpPWpGaD
Fluvoxamine—CYP2E1—nervous system—endogenous depression	0.000313	0.0105	CbGeAlD
Fluvoxamine—SLC6A4—Circadian rythm related genes—CRH—endogenous depression	0.000313	0.0036	CbGpPWpGaD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000312	0.00359	CbGpPWpGaD
Fluvoxamine—CYP1A2—Melatonin metabolism and effects—MAOA—endogenous depression	0.000311	0.00358	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000311	0.00358	CbGpPWpGaD
Fluvoxamine—ABCB1—adrenal cortex—endogenous depression	0.000304	0.0102	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—endogenous depression	0.000301	0.0101	CbGeAlD
Fluvoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000297	0.00342	CbGpPWpGaD
Fluvoxamine—CYP2E1—cerebellum—endogenous depression	0.000294	0.00986	CbGeAlD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000294	0.00339	CbGpPWpGaD
Fluvoxamine—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000293	0.00337	CbGpPWpGaD
Fluvoxamine—SLC6A3—NRF2 pathway—SLC6A4—endogenous depression	0.000286	0.00329	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000278	0.0032	CbGpPWpGaD
Fluvoxamine—ABCB1—cardiovascular system—endogenous depression	0.000278	0.0093	CbGeAlD
Fluvoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00027	0.00312	CbGpPWpGaD
Fluvoxamine—CYP3A4—endocrine gland—endogenous depression	0.000269	0.00901	CbGeAlD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000268	0.00309	CbGpPWpGaD
Fluvoxamine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000267	0.00307	CbGpPWpGaD
Fluvoxamine—CYP2D6—endocrine gland—endogenous depression	0.000265	0.00887	CbGeAlD
Fluvoxamine—CYP1A1—brain—endogenous depression	0.000262	0.00879	CbGeAlD
Fluvoxamine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.00026	0.003	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000258	0.00298	CbGpPWpGaD
Fluvoxamine—CYP2B6—brain—endogenous depression	0.000255	0.00854	CbGeAlD
Fluvoxamine—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.000255	0.00293	CbGpPWpGaD
Fluvoxamine—CYP3A4—nervous system—endogenous depression	0.000252	0.00843	CbGeAlD
Fluvoxamine—CYP2D6—nervous system—endogenous depression	0.000248	0.0083	CbGeAlD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000247	0.00284	CbGpPWpGaD
Fluvoxamine—ABCB1—pituitary gland—endogenous depression	0.000246	0.00823	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—endogenous depression	0.000242	0.00812	CbGeAlD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00024	0.00277	CbGpPWpGaD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000239	0.00276	CbGpPWpGaD
Fluvoxamine—CYP2E1—brain—endogenous depression	0.000239	0.00801	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—endogenous depression	0.000238	0.00799	CbGeAlD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000235	0.0027	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000234	0.0027	CbGpPWpGaD
Fluvoxamine—CYP2D6—cerebellum—endogenous depression	0.000233	0.00781	CbGeAlD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000231	0.00266	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—CYP2D6—endogenous depression	0.000229	0.00263	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000228	0.00263	CbGpPWpGaD
Fluvoxamine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000228	0.00263	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metapathway biotransformation—CYP2D6—endogenous depression	0.000225	0.0026	CbGpPWpGaD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000221	0.00255	CbGpPWpGaD
Fluvoxamine—ABCB1—adrenal gland—endogenous depression	0.00022	0.00736	CbGeAlD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000219	0.00253	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000218	0.00252	CbGpPWpGaD
Fluvoxamine—ABCB1—midbrain—endogenous depression	0.000217	0.00726	CbGeAlD
Fluvoxamine—SLC6A3—Neuronal System—CACNB2—endogenous depression	0.000213	0.00245	CbGpPWpGaD
Fluvoxamine—ABCB1—thyroid gland—endogenous depression	0.000212	0.0071	CbGeAlD
Fluvoxamine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000211	0.00243	CbGpPWpGaD
Fluvoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000192	0.00222	CbGpPWpGaD
Fluvoxamine—ABCB1—endocrine gland—endogenous depression	0.00019	0.00638	CbGeAlD
Fluvoxamine—CYP2D6—brain—endogenous depression	0.000189	0.00634	CbGeAlD
Fluvoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000188	0.00217	CbGpPWpGaD
Fluvoxamine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000188	0.00217	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000187	0.00216	CbGpPWpGaD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000181	0.00208	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000178	0.00205	CbGpPWpGaD
Fluvoxamine—ABCB1—nervous system—endogenous depression	0.000178	0.00597	CbGeAlD
Fluvoxamine—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000178	0.00205	CbGpPWpGaD
Fluvoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000176	0.00203	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—COMT—endogenous depression	0.000173	0.002	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—MAOA—endogenous depression	0.000172	0.00198	CbGpPWpGaD
Fluvoxamine—ABCB1—central nervous system—endogenous depression	0.000172	0.00575	CbGeAlD
Fluvoxamine—CYP3A7—Metapathway biotransformation—COMT—endogenous depression	0.000171	0.00197	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—CYP2D6—endogenous depression	0.000169	0.00195	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—COMT—endogenous depression	0.000168	0.00194	CbGpPWpGaD
Fluvoxamine—ABCB1—cerebellum—endogenous depression	0.000168	0.00562	CbGeAlD
Fluvoxamine—SLC6A3—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000167	0.00193	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—CYP2D6—endogenous depression	0.000167	0.00192	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000166	0.00192	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—CYP2D6—endogenous depression	0.000166	0.00191	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—CYP2D6—endogenous depression	0.000165	0.0019	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000165	0.0019	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000163	0.00188	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—CYP2D6—endogenous depression	0.000163	0.00188	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000161	0.00186	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—CYP2D6—endogenous depression	0.000156	0.0018	CbGpPWpGaD
Fluvoxamine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000156	0.0018	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000154	0.00177	CbGpPWpGaD
Fluvoxamine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000153	0.00176	CbGpPWpGaD
Fluvoxamine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000152	0.00176	CbGpPWpGaD
Fluvoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000145	0.00167	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000145	0.00167	CbGpPWpGaD
Fluvoxamine—CYP1A1—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000144	0.00166	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000141	0.00162	CbGpPWpGaD
Fluvoxamine—ABCB1—brain—endogenous depression	0.000136	0.00456	CbGeAlD
Fluvoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000134	0.00154	CbGpPWpGaD
Fluvoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000133	0.00153	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—COMT—endogenous depression	0.000129	0.00149	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.000129	0.00149	CbGpPWpGaD
Fluvoxamine—SLC6A3—Neuronal System—MAOA—endogenous depression	0.000128	0.00148	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—COMT—endogenous depression	0.000128	0.00148	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—CYP2D6—endogenous depression	0.000128	0.00147	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—MAOA—endogenous depression	0.000127	0.00147	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—COMT—endogenous depression	0.000126	0.00146	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—CYP2D6—endogenous depression	0.000126	0.00145	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—COMT—endogenous depression	0.000125	0.00145	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—COMT—endogenous depression	0.000125	0.00144	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—MAOA—endogenous depression	0.000125	0.00144	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—MAOA—endogenous depression	0.000124	0.00143	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metapathway biotransformation—COMT—endogenous depression	0.000124	0.00143	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—COMT—endogenous depression	0.000124	0.00142	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—COMT—endogenous depression	0.000118	0.00136	CbGpPWpGaD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000118	0.00136	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—MAOA—endogenous depression	0.000117	0.00135	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—COMT—endogenous depression	0.000117	0.00134	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP2D6—endogenous depression	0.000116	0.00134	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—CYP2D6—endogenous depression	0.000115	0.00132	CbGpPWpGaD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000113	0.0013	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—POMC—endogenous depression	0.000112	0.00129	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000109	0.00125	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000108	0.00125	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000107	0.00124	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	9.95e-05	0.00115	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	9.82e-05	0.00113	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—COMT—endogenous depression	9.68e-05	0.00112	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—MAOA—endogenous depression	9.61e-05	0.00111	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—COMT—endogenous depression	9.55e-05	0.0011	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	9.18e-05	0.00106	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—COMT—endogenous depression	8.9e-05	0.00103	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—MAOA—endogenous depression	8.84e-05	0.00102	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—COMT—endogenous depression	8.83e-05	0.00102	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	8.78e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—MAOA—endogenous depression	8.76e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	8.74e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—COMT—endogenous depression	8.71e-05	0.001	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	8.32e-05	0.000959	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—POMC—endogenous depression	8.28e-05	0.000954	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—POMC—endogenous depression	8.11e-05	0.000934	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—POMC—endogenous depression	8.09e-05	0.000932	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	7.68e-05	0.000885	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—POMC—endogenous depression	7.65e-05	0.000881	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	7.58e-05	0.000873	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—COMT—endogenous depression	7.54e-05	0.000869	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—MAOA—endogenous depression	7.49e-05	0.000863	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	7.44e-05	0.000857	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.08e-05	0.000816	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TPH1—endogenous depression	6.45e-05	0.000743	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—POMC—endogenous depression	6.26e-05	0.000721	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—COMT—endogenous depression	5.82e-05	0.000671	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—MAOA—endogenous depression	5.78e-05	0.000666	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—POMC—endogenous depression	5.76e-05	0.000663	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	5.74e-05	0.000661	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—POMC—endogenous depression	5.71e-05	0.000657	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TPH2—endogenous depression	4.89e-05	0.000563	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CACNB2—endogenous depression	4.89e-05	0.000563	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—POMC—endogenous depression	4.88e-05	0.000562	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—DPYD—endogenous depression	4.81e-05	0.000554	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TPH1—endogenous depression	4.77e-05	0.00055	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TPH1—endogenous depression	4.67e-05	0.000538	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TPH1—endogenous depression	4.66e-05	0.000537	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CACNA1C—endogenous depression	4.47e-05	0.000515	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TPH1—endogenous depression	4.41e-05	0.000508	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP2D6—endogenous depression	3.91e-05	0.00045	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—POMC—endogenous depression	3.76e-05	0.000434	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TPH2—endogenous depression	3.62e-05	0.000417	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CACNB2—endogenous depression	3.62e-05	0.000417	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TPH1—endogenous depression	3.61e-05	0.000415	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—DPYD—endogenous depression	3.56e-05	0.00041	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TPH2—endogenous depression	3.54e-05	0.000408	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CACNB2—endogenous depression	3.54e-05	0.000408	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TPH2—endogenous depression	3.53e-05	0.000407	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CACNB2—endogenous depression	3.53e-05	0.000407	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TPH1—endogenous depression	3.52e-05	0.000405	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—DPYD—endogenous depression	3.48e-05	0.000401	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—DPYD—endogenous depression	3.48e-05	0.000401	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TPH2—endogenous depression	3.34e-05	0.000385	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CACNB2—endogenous depression	3.34e-05	0.000385	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TPH1—endogenous depression	3.32e-05	0.000382	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CACNA1C—endogenous depression	3.31e-05	0.000381	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TPH1—endogenous depression	3.29e-05	0.000379	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—DPYD—endogenous depression	3.29e-05	0.000378	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CACNA1C—endogenous depression	3.24e-05	0.000373	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CACNA1C—endogenous depression	3.23e-05	0.000372	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CACNA1C—endogenous depression	3.05e-05	0.000352	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—COMT—endogenous depression	2.96e-05	0.000341	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MAOA—endogenous depression	2.94e-05	0.000339	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.94e-05	0.000338	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2D6—endogenous depression	2.89e-05	0.000333	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP2D6—endogenous depression	2.83e-05	0.000326	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2D6—endogenous depression	2.83e-05	0.000326	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TPH1—endogenous depression	2.81e-05	0.000324	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TPH2—endogenous depression	2.73e-05	0.000315	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CACNB2—endogenous depression	2.73e-05	0.000315	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—DPYD—endogenous depression	2.69e-05	0.00031	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2D6—endogenous depression	2.67e-05	0.000308	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TPH2—endogenous depression	2.67e-05	0.000307	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CACNB2—endogenous depression	2.67e-05	0.000307	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—DPYD—endogenous depression	2.62e-05	0.000302	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TPH2—endogenous depression	2.51e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CACNB2—endogenous depression	2.51e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CACNA1C—endogenous depression	2.5e-05	0.000288	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TPH2—endogenous depression	2.49e-05	0.000287	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CACNB2—endogenous depression	2.49e-05	0.000287	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—DPYD—endogenous depression	2.47e-05	0.000285	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—DPYD—endogenous depression	2.45e-05	0.000282	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CACNA1C—endogenous depression	2.44e-05	0.000281	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.4e-05	0.000277	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CACNA1C—endogenous depression	2.3e-05	0.000265	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CACNA1C—endogenous depression	2.28e-05	0.000263	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—endogenous depression	2.19e-05	0.000252	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—COMT—endogenous depression	2.19e-05	0.000252	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2D6—endogenous depression	2.18e-05	0.000252	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOA—endogenous depression	2.18e-05	0.000251	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TPH1—endogenous depression	2.17e-05	0.00025	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—COMT—endogenous depression	2.15e-05	0.000247	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—COMT—endogenous depression	2.14e-05	0.000247	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2D6—endogenous depression	2.13e-05	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOA—endogenous depression	2.13e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TPH2—endogenous depression	2.13e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CACNB2—endogenous depression	2.13e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOA—endogenous depression	2.13e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—DPYD—endogenous depression	2.09e-05	0.000241	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—COMT—endogenous depression	2.02e-05	0.000233	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOA—endogenous depression	2.01e-05	0.000231	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2D6—endogenous depression	1.99e-05	0.000229	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CACNA1C—endogenous depression	1.95e-05	0.000224	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POMC—endogenous depression	1.92e-05	0.000221	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	1.87e-05	0.000216	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2D6—endogenous depression	1.7e-05	0.000196	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—COMT—endogenous depression	1.66e-05	0.000191	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOA—endogenous depression	1.64e-05	0.000189	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TPH2—endogenous depression	1.64e-05	0.000189	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CACNB2—endogenous depression	1.64e-05	0.000189	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—DPYD—endogenous depression	1.62e-05	0.000186	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—COMT—endogenous depression	1.62e-05	0.000186	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOA—endogenous depression	1.6e-05	0.000185	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—COMT—endogenous depression	1.52e-05	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOA—endogenous depression	1.51e-05	0.000174	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—COMT—endogenous depression	1.51e-05	0.000174	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CACNA1C—endogenous depression	1.5e-05	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOA—endogenous depression	1.5e-05	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—endogenous depression	1.42e-05	0.000163	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—endogenous depression	1.39e-05	0.00016	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—endogenous depression	1.38e-05	0.000159	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2D6—endogenous depression	1.31e-05	0.000151	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—endogenous depression	1.31e-05	0.000151	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—COMT—endogenous depression	1.29e-05	0.000149	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOA—endogenous depression	1.28e-05	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—endogenous depression	1.07e-05	0.000123	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—endogenous depression	1.04e-05	0.00012	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—COMT—endogenous depression	9.96e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOA—endogenous depression	9.89e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—endogenous depression	9.84e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—endogenous depression	9.76e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—endogenous depression	8.34e-06	9.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—endogenous depression	6.44e-06	7.41e-05	CbGpPWpGaD
